ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2111

The Impact Of Centralized Pain On Long-Term Analgesic Response To Lower Extremity Joint Arthroplasty:  A Prospective, Observational Cohort Study

Chad M. Brummett1, Andrew Urquhart2, Brian Hallstrom2, Alex Tsodikov3, David A. Williams4 and Daniel J. Clauw5, 1Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI, 2Orthopedics, University of Michigan Health System, Ann Arbor, MI, 3Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, 4Chronic Pain & Fatigue Rsch Ctr, Univ of MI Hlth System-Lobby M, Ann Arbor, MI, 5Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Arthroplasty, fibromyalgia and pain, Hip, Knee

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Orthopedics, Low Back Pain and Rehabilitation

Session Type: Abstract Submissions (ACR)

Background/Purpose :  In cross-sectional studies, depression and pain in other locations have been reported as predicting poorer outcomes following total knee and hip arthroplasty.  These factors may be better explained by a common pathophysiology of aberrant central pain processing as is seen in conditions like fibromyalgia. We hypothesized that patients with altered central pain processing would be less likely to report pain improvement after lower extremity joint arthroplasty.

Methods : Patients were preoperatively phenotyped using validated self-reported, including the Brief Pain Inventory, PainDETECT, WOMAC, Hospital Anxiety and Depression Scale, Catastrophizing, health information (opioid use, ASA Status, BMI, primary anesthetic), and demographics. Participants also completed the American College of Rheumatology (ACR) survey criteria for fibromyalgia as a surrogate of centralized pain, which is a measure of widespread pain and an assessment of symptoms such as fatigue or trouble thinking.  Patients were re-assessed using the same preoperative phenotype at 6-months postoperatively.  Data were analyzed using R 2.15.2.  A linear model was used to regress the change in pain responses at surgical site and overall on a set of covariates including the baseline pain value.

Results :  598 of the 851 patients approached agreed to participate (70.3%).  A total of 454 patients completed the 6-month outcome follow-up (75.9%) and were included in the outcome analyses.  Preoperatively, patients with higher fibromyalgia survey scores were significantly younger, more likely to be female, less educated, more likely to be on disability or unemployed, and more likely to be taking preoperative opioids (p < 0.05 for each comparison).  Patients with higher scores on the fibromyalgia survey also reported higher pain severity overall and at the surgical site, higher WOMAC scores, and had a more negative psychological profile (p < 0.0001 for each comparison).  When adjusting for other covariates, patients with higher preoperative pain and educational status showed more improvement in overall pain (Table 1).  Higher fibromyalgia survey scores, higher BMI, use of opioids preoperatively, and African American race were independently predictive of less improvement in pain overall.  Similar results were obtained when regressing for the change in surgical site pain.

Conclusion :  In this large, prospective, observational cohort study, the ACR survey criteria for fibromyalgia differentiated patients preoperatively and was independently predictive of poorer long-term outcomes when assessing both the change in the surgical site and overall body pain.  Altered central pain processing may explain some of the variance in outcomes previously described in lower extremity joint arthroplasty.  This simple, validated, self-report measure may add value in selecting appropriate candidates for arthroplasty. 


Disclosure:

C. M. Brummett,

Purdue Pharma L.P.,

5;

A. Urquhart,
None;

B. Hallstrom,
None;

A. Tsodikov,
None;

D. A. Williams,

Purdue Pharma L.P.,

5,

Forest Pharmaceuticals,

5,

Pfizer Inc,

5;

D. J. Clauw,

Nuvo, Merck, Cerephex, Pfizer,

2,

Lilly, Pfizer, Forest, Nuvo, Cerephex, Purdue,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-centralized-pain-on-long-term-analgesic-response-to-lower-extremity-joint-arthroplasty-a-prospective-observational-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology